SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Merriam N.) "

Search: WFRF:(Merriam N.)

  • Result 1-3 of 3
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Holsti, N., et al. (author)
  • WCET Tool Challenge 2008 : Report
  • 2008
  • In: OpenAccess Ser. Informatics. - 9783939897101
  • Conference paper (peer-reviewed)abstract
    • Following the successful WCET Tool Challenge in 2006, the second event in this series was organized in 2008, again with support from the ARTIST2 Network of Excellence. The WCET Tool Challenge 2008 (WCC'08) provides benchmark programs and poses a number of "analysis problems" about the dynamic, runtime properties of these programs. The participants are challenged to solve these problems with their programanalysis tools. Two kinds of problems are defined: WCET problems, which ask for bounds on the execution time of chosen parts (subprograms) of the benchmarks, under given constraints on input data; and flowanalysis problems, which ask for bounds on the number of times certain parts of the benchmark can be executed, again under some constraints. We describe the organization of WCC'08, the benchmark programs, the participating tools, and the general results, successes, and failures. Most participants found WCC'08 to be a useful test of their tools. Unlike the 2006 Challenge, the WCC'08 participants include several tools for the same target (ARM7, LPC2138), and tools that combine measurements and static analysis, as well as pure staticanalysis tools.
  •  
2.
  • Stacchiotti, S., et al. (author)
  • Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
  • 2021
  • In: ESMO Open. - : Elsevier BV. - 2059-7029. ; 6:3
  • Research review (peer-reviewed)abstract
    • Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. No active systemic agents are currently approved specifically for EHE, which is typically refractory to the antitumor drugs used in sarcomas. The degree of uncertainty in selecting the most appropriate therapy for EHE patients and the lack of guidelines on the clinical management of the disease make the adoption of new treatments inconsistent across the world, resulting in suboptimal outcomes for many EHE patients. To address the shortcoming, a global consensus meeting was organized in December 2020 under the umbrella of the European Society for Medical Oncology (ESMO) involving >80 experts from several disciplines from Europe, North America and Asia, together with a patient representative from the EHE Group, a global, disease-specific patient advocacy group, and Sarcoma Patient EuroNet (SPAEN). The meeting was aimed at defining, by consensus, evidence-based best practices for the optimal approach to primary and metastatic EHE. The consensus achieved during that meeting is the subject of the present publication.
  •  
3.
  • Merriam, N., et al. (author)
  • Estimation of productivity increase for timing analysis tool chains
  • 2013
  • In: International Journal on Software Tools for Technology Transfer. - : Springer Science and Business Media LLC. - 1433-2779 .- 1433-2787. ; 15:1, s. 65-84
  • Journal article (peer-reviewed)abstract
    • Within the scope of the ALL-TIMES project, not only were tool interfaces designed and implemented but also new, powerful timing analysis methodologies constructed. To gauge the effectiveness of these results we used a number of methods to assess the productivity increase that would be achieved by introducing the new techniques. We collect and report on the conclusions of these assessments. © 2012 Springer-Verlag.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-3 of 3

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view